Stephane Allard

Title: The Innovations of Stephane Allard

Introduction

Stephane Allard is an accomplished inventor based in Englewood, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. His work focuses on improving the efficacy and delivery of medications.

Latest Patents

Allard holds a patent for an extended release formulation of a direct thrombin inhibitor. This patent, titled "Extended release formulations of 3-fluoro-2-pyridylmethyl-3-(2,2-difluoro-2-(2-pyridyl)ethylamino)-6-chloropyrazin-2-one-1-acetamide (DPOC-4088)," provides for better control of blood plasma levels. The extended release formulations maintain substantially constant plasma levels of the active ingredient for at least about 16 hours and allow for once-daily dosing. He has 1 patent to his name.

Career Highlights

Allard is currently employed at Diakron Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work is pivotal in developing formulations that enhance patient compliance and therapeutic outcomes.

Collaborations

Throughout his career, Allard has collaborated with notable colleagues, including Sankar Ramakrishnan and Elumalal Venkatesan. These partnerships have contributed to the advancement of his research and the successful development of new pharmaceutical products.

Conclusion

Stephane Allard's contributions to the field of pharmaceuticals through his innovative patent and collaborative efforts highlight his commitment to improving healthcare solutions. His work exemplifies the impact of dedicated inventors in advancing medical science.